144 related articles for article (PubMed ID: 28542371)
1. Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline.
Giannoulatou E; Maher GJ; Ding Z; Gillis AJM; Dorssers LCJ; Hoischen A; Rajpert-De Meyts E; ; McVean G; Wilkie AOM; Looijenga LHJ; Goriely A
PLoS One; 2017; 12(5):e0178169. PubMed ID: 28542371
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the mixed germ cell-sex cord stromal tumor of the testis: detection of chromosomal aneuploidy and further morphological evidence supporting the neoplastic nature of the germ cell component.
Michalova K; McKenney JK; Kristiansen G; Steiner P; Grossmann P; Putzova M; Martinek P; Chottova-Dvorakova M; Michal M; Hes O; Michal M
Virchows Arch; 2020 Nov; 477(5):615-623. PubMed ID: 32447491
[TBL] [Abstract][Full Text] [Related]
3. [Spermatocytic seminoma. A tumor with many faces].
Mikuz G
Pathologe; 2014 May; 35(3):232-7. PubMed ID: 24682373
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors.
Goriely A; Hansen RM; Taylor IB; Olesen IA; Jacobsen GK; McGowan SJ; Pfeifer SP; McVean GA; Rajpert-De Meyts E; Wilkie AO
Nat Genet; 2009 Nov; 41(11):1247-52. PubMed ID: 19855393
[TBL] [Abstract][Full Text] [Related]
5. OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia.
Lim J; Goriely A; Turner GD; Ewen KA; Jacobsen GK; Graem N; Wilkie AO; Rajpert-De Meyts E
J Pathol; 2011 Aug; 224(4):473-83. PubMed ID: 21706474
[TBL] [Abstract][Full Text] [Related]
6. Genomic and expression profiling of human spermatocytic seminomas: pathogenetic implications.
Looijenga LH; Stoop H; Hersmus R; Gillis AJ; Wolter Oosterhuis J
Int J Androl; 2007 Aug; 30(4):328-35; discussion 335-6. PubMed ID: 17573843
[TBL] [Abstract][Full Text] [Related]
7. De novo structural mutation rates and gamete-of-origin biases revealed through genome sequencing of 2,396 families.
Belyeu JR; Brand H; Wang H; Zhao X; Pedersen BS; Feusier J; Gupta M; Nicholas TJ; Brown J; Baird L; Devlin B; Sanders SJ; Jorde LB; Talkowski ME; Quinlan AR
Am J Hum Genet; 2021 Apr; 108(4):597-607. PubMed ID: 33675682
[TBL] [Abstract][Full Text] [Related]
8. The genetic landscape of 87 ovarian germ cell tumors.
Van Nieuwenhuysen E; Busschaert P; Neven P; Han SN; Moerman P; Liontos M; Papaspirou M; Kupryjanczyk J; Hogdall C; Hogdall E; Oaknin A; Garcia A; Mahner S; Trillsch F; Cibula D; Heitz F; Concin N; Speiser P; Salvesen H; Sehouli J; Lambrechts D; Vergote I
Gynecol Oncol; 2018 Oct; 151(1):61-68. PubMed ID: 30170975
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.
Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M
Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316
[TBL] [Abstract][Full Text] [Related]
10. Rare de novo germline copy-number variation in testicular cancer.
Stadler ZK; Esposito D; Shah S; Vijai J; Yamrom B; Levy D; Lee YH; Kendall J; Leotta A; Ronemus M; Hansen N; Sarrel K; Rau-Murthy R; Schrader K; Kauff N; Klein RJ; Lipkin SM; Murali R; Robson M; Sheinfeld J; Feldman D; Bosl G; Norton L; Wigler M; Offit K
Am J Hum Genet; 2012 Aug; 91(2):379-83. PubMed ID: 22863192
[TBL] [Abstract][Full Text] [Related]
11. Protein expression of the transcription factors DMRT1, TCLF5, and OCT4 in selected germ cell neoplasms of the testis.
Roth LM; Michal M; Michal M; Cheng L
Hum Pathol; 2018 Dec; 82():68-75. PubMed ID: 30067948
[TBL] [Abstract][Full Text] [Related]
12. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
[TBL] [Abstract][Full Text] [Related]
13. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene.
Looijenga LH; Hersmus R; Gillis AJ; Pfundt R; Stoop HJ; van Gurp RJ; Veltman J; Beverloo HB; van Drunen E; van Kessel AG; Pera RR; Schneider DT; Summersgill B; Shipley J; McIntyre A; van der Spek P; Schoenmakers E; Oosterhuis JW
Cancer Res; 2006 Jan; 66(1):290-302. PubMed ID: 16397242
[TBL] [Abstract][Full Text] [Related]
14. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
[TBL] [Abstract][Full Text] [Related]
15. Molecular correlates of male germ cell tumors with overgrowth of components resembling somatic malignancies.
Wyvekens N; Sholl LM; Yang Y; Tran I; Vasudevaraja V; Dickson BC; Al-Obaidy KI; Baniak N; Collins K; Gordetsky JB; Idrees MT; Kao CS; Maclean F; Matoso A; Ulbright TM; Wobker SE; Fletcher CDM; Hirsch MS; Hornick JL; Snuderl M; Acosta AM
Mod Pathol; 2022 Dec; 35(12):1966-1973. PubMed ID: 36030288
[TBL] [Abstract][Full Text] [Related]
16. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
17. Cellular evidence for selfish spermatogonial selection in aged human testes.
Maher GJ; Goriely A; Wilkie AO
Andrology; 2014 May; 2(3):304-14. PubMed ID: 24357637
[TBL] [Abstract][Full Text] [Related]
18. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.
Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB
Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411
[TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.
Litchfield K; Summersgill B; Yost S; Sultana R; Labreche K; Dudakia D; Renwick A; Seal S; Al-Saadi R; Broderick P; Turner NC; Houlston RS; Huddart R; Shipley J; Turnbull C
Nat Commun; 2015 Jan; 6():5973. PubMed ID: 25609015
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
